Addus HomeCare (NASDAQ:ADUS) EVP Brian Poff Sells 6,644 Shares of Company Stock

Addus HomeCare Corporation (NASDAQ:ADUS) EVP Brian Poff sold 6,644 shares of Addus HomeCare stock in a transaction dated Friday, November 6th. The stock was sold at an average price of $124.72, for a total value of $828,639.68. Following the transaction, the executive vice president directly owned 57,048 shares in the company, valued at $7,115,026.56. The trade was a 10.43% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this link.

Addus HomeCare Trading Up 3.2%

NASDAQ ADUS opened at $126.29 on Wednesday. The firm has a market capitalization of $2.35 billion, a PE ratio of 21.05, a price-to-earnings-growth ratio of 1.62 and a beta of 0.75. The business’s 50-day moving average price is $117.97 and its two-hundred day moving average price is $107.02. The company has a current ratio of 1.64, a quick ratio of 1.64 and a debt-to-equity ratio of 0.02. Addus HomeCare Corporation has a 12 month low of $87.95 and a 12 month high of $131.59.

Addus HomeCare (NASDAQ:ADUS) last issued its quarterly earnings data on Tuesday, November 3rd. The company reported $1.83 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.79 by $0.04. The company had revenue of $387.74 million during the quarter, compared to the consensus estimate of $388.72 million. Addus HomeCare had a return on equity of 10.22% and a net margin of 7.39%. The firm’s revenue was up 7.0% compared to the same quarter last year. During the same period last year, the company earned $1.56 earnings per share. On average, analysts expect that Addus HomeCare Corporation will post 6.36 EPS for the current year.

Hedge Funds Weigh In On Addus HomeCare

Several institutional investors have recently made changes to their positions in the stock. Hsbc Holdings PLC grew its stake in shares of Addus HomeCare by 73.3% in the 2nd quarter. Hsbc Holdings PLC now owns 24,463 shares of the company’s stock valued at $2,446,000 after buying an additional 10,350 shares during the period. Summit Creek Advisors LLC bought a new stake in Addus HomeCare in the 2nd quarter valued at about $8,552,000. Bank of America Corp DE increased its position in Addus HomeCare by 11.3% in the 1st quarter. Bank of America Corp DE now owns 323,037 shares of the company’s stock valued at $30,252,000 after buying an additional 32,714 shares in the last quarter. Globeflex Capital L P acquired a new position in Addus HomeCare during the 2nd quarter worth approximately $1,635,000. Finally, The Manufacturers Life Insurance Company acquired a new position in Addus HomeCare during the 2nd quarter worth approximately $901,000. Institutional investors and hedge funds own 95.35% of the company’s stock.

Trending Headlines about Addus HomeCare

Here are the key news stories impacting Addus HomeCare this week:

• Neutral Sentiment: Addus said it will participate in the 2026 Stephens Annual Investment Conference. The announcement provides an opportunity to meet investors but gives no new financial or operating guidance. Article: Addus HomeCare to Participate in 2026 Stephens Annual Investment Conference
• Neutral Sentiment: A report listed short interest at zero shares, indicating no reported short position; however, its description of a “large increase” conflicts with that figure.
• Negative Sentiment: Several executives disclosed stock sales. CEO R. Allison sold 98,958 shares for about $12.2 million, reducing his holding by 35.08%. Five EVPs collectively sold 32,697 shares for roughly $4.1 million. Insider sales can weigh on sentiment, although they do not by themselves establish a negative outlook. CEO sale filing EVP sale filing EVP sale filing EVP sale filing EVP sale filing EVP sale filing

Wall Street Analysts Forecast Growth

A number of analysts have weighed in on the stock. Royal Bank Of Canada increased their target price on shares of Addus HomeCare from $130.00 to $134.00 and gave the company an “outperform” rating in a research report on Wednesday, August 5th. Raymond James Financial set a $137.00 price target on shares of Addus HomeCare in a research report on Monday, September 28th. Weiss Ratings raised shares of Addus HomeCare from a “hold (c)” rating to a “hold (c+)” rating in a research note on Thursday, September 24th. Wall Street Zen upgraded shares of Addus HomeCare from a “buy” rating to a “strong-buy” rating in a research report on Saturday. Finally, UBS Group increased their price objective on shares of Addus HomeCare from $145.00 to $160.00 and gave the stock a “buy” rating in a research report on Thursday, November 5th. Seven investment analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $134.70.

Addus HomeCare Company Profile

Addus HomeCare Corporation provides home-based care services to older adults and people with disabilities. Its services are designed to help clients receive care at home and in other community-based settings. The company operates through personal care, hospice and home health services. Personal care includes assistance with daily activities; hospice provides end-of-life care and support; and home health offers skilled nursing and therapy services. Founded in 1979, Addus serves communities across multiple states.